| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Nov―12 |
Safety observation of COVID-19 inactivated vaccine in immature mice |
Jingxuan Zhou, Yingyan Han, Xiaoyuan Huang, Zhegang Zhang, Jiayou Zhang, Teng Ji |
| 2 |
[GO] |
2023―Jun―19 |
Targeting the cGAS-STING pathway as an inflammatory crossroad in coronavirus disease 2019 (COVID-19) |
Reza Elahi, Salar Hozhabri, Amirhosein Moradi, Amir Siahmansouri, Armin Jahani Maleki, Abdolreza Esmaeilzadeh |
| 3 |
[GO] |
2022―Dez―20 |
Effects of Sulfasalazine in Axial Spondyloarthritis on COVID-19 Outcomes: Real-life Data from a Single Center |
Berkan Armağan, Ebru Atalar, Serdar Can Güven, Bahar Özdemir, Hatice Ecem Konak, Pınar Akyüz Dağlı, et al. (+7) Abdulsamet Erden, Kevser Gök, Yüksel Maraş, İsmail Doğan, Orhan Küçükşahin, Şükran Erten, Ahmet Omma |
| 4 |
[GO] |
2022―Dez―20 |
Sotrovimab therapy in solid organ transplant recipients with mild to moderate COVID-19: a systematic review and meta-analysis |
Negin Farhadian, Maryam Farhadian, Mohammad Hossein Zamanian, Mahdi Taghadosi, Siavash Vaziri |
| 5 |
[GO] |
2022―Okt―19 |
Neutrophil Extracellular Traps (NET) and SARS-CoV-2 |
Shaghayegh Pezeshki |
| 6 |
[GO] |
2022―Mai―04 |
Absence of active systemic anaphylaxis in guinea pigs upon intramuscular injection of inactivated SARS-CoV-2 vaccine (Vero cells) |
Zhangqiong Huang, Yun Li, Hongkun Yi, Zhengcun Wu, Cong Li, Tingfu Du, et al. (+9) Jinling Yang, Yixuan Wang, Qinfang Jiang, Shengtao Fan, Yun Liao, Ying Zhang, Guorun Jiang, Kaili Ma, Qihan Li |
| 7 |
[GO] |
2021―Nov―11 |
The use of neutralizing monoclonal antibodies and risk of hospital admission and mortality in patients with COVID-19: a systematic review and meta-analysis of randomized trials |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 8 |
[GO] |
2021―Okt―26 |
Interferon-α2b induced anemia in severe coronavirus disease 2019 patients: a single centered, retrospective study |
Xina Li, Tong Liu, Xin Hai, Le Li |
| 9 |
[GO] |
2021―Okt―16 |
Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19 |
Malek Zarei, Navideh Sahebi Vaighan, Seyed Ali Ziai |
| 10 |
[GO] |
2021―Jul―21 |
A systematic review on efficacy, safety, and treatment-durability of low-dose rituximab for the treatment of Pemphigus: special focus on COVID-19 pandemic concerns |
Soheil Tavakolpour, Zeinab Aryanian, Farnoosh Seirafianpour, Milad Dodangeh, Ifa Etesami, Maryam Daneshpazhooh, et al. (+3) Kamran Balighi, Hamidreza Mahmoudi, Azadeh Goodarzi |
| 11 |
[GO] |
2021―Jun―01 |
Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance |
Payam Hashemi, Shaghayegh Pezeshki |
| 12 |
[GO] |
2021―Jun―01 |
Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications |
May Ahmed Shawki, Noha Salah Elsayed, Eman M. Mantawy, Riham S. Said |
| 13 |
[GO] |
2021―Mai―21 |
Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19 |
Ali Saeedi-Boroujeni, Mohammad-Reza Mahmoudian-Sani, Roohangiz Nashibi, Sheyda Houshmandfar, Sima Tahmaseby Gandomkari, Ali Khodadadi |
| 14 |
[GO] |
2021―Mai―21 |
Anti-IgE monoclonal antibodies as potential treatment in COVID-19 |
Ahmad Reza Farmani, Forough Mahdavinezhad, Rohollah Moslemi, Zeinab Mehrabi, Alireza Noori, Mahsa Kouhestani, et al. (+3) Zahra Noroozi, Jafar Ai, Nima Rezaei |
| 15 |
[GO] |
2021―Jan―07 |
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility |
Tarek Kashour, Rabih Halwani, Yaseen M. Arabi, M. Rizwan Sohail, John C. O’Horo, Andrew D. Badley, Imad M. Tleyjeh |
| 16 |
[GO] |
2020―Dez―28 |
Different aspects of convalescent plasma therapy for COVID-19 treatment; a critical review |
Sitaram Khadka, Shameem Nisar, Nawazish-i-Husain Syed, Dhan Bahadur Shrestha, Pravash Budhathoki |
| 17 |
[GO] |
2020―Okt―27 |
Biochemical and immunological aspects of Covid-19 infection and therapeutical intervention of oral low dose cytokine therapy: A systematic review |
Ratheesh M, Sheethal S, Svenia P Jose, Sony Rajan, Sulumol Thomas, Tariq Jagmag, Jayesh Tilwani |
| 18 |
[GO] |
2020―Okt―15 |
Deciphering Vaccines for COVID-19: Where do we stand TODAY? |
Tushar Baviskar, Dezaree Raut, Lokesh Kumar Bhatt |
| 19 |
[GO] |
2020―Sep―04 |
Future Perspective: Biologic agents in patients with Severe Covid-19 |
Arzu Didem Yalcin, Ata Nevzat Yalcin |
